CN111394245B - 用于筛选对内皮糖萼相关疾病具有预防和治疗活性的化合物的方法和装置 - Google Patents
用于筛选对内皮糖萼相关疾病具有预防和治疗活性的化合物的方法和装置 Download PDFInfo
- Publication number
- CN111394245B CN111394245B CN201911275786.7A CN201911275786A CN111394245B CN 111394245 B CN111394245 B CN 111394245B CN 201911275786 A CN201911275786 A CN 201911275786A CN 111394245 B CN111394245 B CN 111394245B
- Authority
- CN
- China
- Prior art keywords
- endothelial
- chamber
- cell culture
- endothelial cells
- glycocalyx
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920002306 Glycocalyx Polymers 0.000 title claims description 98
- 210000004517 glycocalyx Anatomy 0.000 title claims description 98
- 230000003511 endothelial effect Effects 0.000 title claims description 87
- 238000000034 method Methods 0.000 title claims description 62
- 150000001875 compounds Chemical class 0.000 title claims description 20
- 238000012216 screening Methods 0.000 title description 10
- 230000001225 therapeutic effect Effects 0.000 title description 4
- 201000010099 disease Diseases 0.000 title description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 2
- 230000000069 prophylactic effect Effects 0.000 title description 2
- 239000012528 membrane Substances 0.000 claims abstract description 62
- 230000033001 locomotion Effects 0.000 claims abstract description 6
- 210000002889 endothelial cell Anatomy 0.000 claims description 47
- 210000004027 cell Anatomy 0.000 claims description 31
- 239000006143 cell culture medium Substances 0.000 claims description 30
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 28
- 239000008103 glucose Substances 0.000 claims description 28
- 230000035699 permeability Effects 0.000 claims description 26
- 229920002307 Dextran Polymers 0.000 claims description 19
- 238000004624 confocal microscopy Methods 0.000 claims description 16
- 238000012360 testing method Methods 0.000 claims description 15
- 238000010899 nucleation Methods 0.000 claims description 13
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 11
- 210000000329 smooth muscle myocyte Anatomy 0.000 claims description 11
- 230000006378 damage Effects 0.000 claims description 10
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 9
- 238000001727 in vivo Methods 0.000 claims description 9
- 238000011081 inoculation Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 9
- 230000003345 hyperglycaemic effect Effects 0.000 claims description 8
- 210000000265 leukocyte Anatomy 0.000 claims description 8
- 230000017531 blood circulation Effects 0.000 claims description 7
- 230000012010 growth Effects 0.000 claims description 7
- 210000004618 arterial endothelial cell Anatomy 0.000 claims description 6
- 210000004925 microvascular endothelial cell Anatomy 0.000 claims description 6
- -1 polydimethylsiloxane Polymers 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- 230000002685 pulmonary effect Effects 0.000 claims description 6
- 229920000515 polycarbonate Polymers 0.000 claims description 5
- 239000004417 polycarbonate Substances 0.000 claims description 5
- 210000003606 umbilical vein Anatomy 0.000 claims description 5
- 108010046516 Wheat Germ Agglutinins Proteins 0.000 claims description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 4
- 229920002401 polyacrylamide Polymers 0.000 claims description 4
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 4
- 241000283690 Bos taurus Species 0.000 claims description 3
- 210000002403 aortic endothelial cell Anatomy 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 206010012601 diabetes mellitus Diseases 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 230000001681 protective effect Effects 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 239000000017 hydrogel Substances 0.000 claims description 2
- 230000002427 irreversible effect Effects 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 238000001243 protein synthesis Methods 0.000 claims description 2
- 238000005086 pumping Methods 0.000 claims description 2
- 238000005096 rolling process Methods 0.000 claims description 2
- 230000014616 translation Effects 0.000 claims description 2
- 210000003954 umbilical cord Anatomy 0.000 claims description 2
- 238000004113 cell culture Methods 0.000 description 80
- 208000024172 Cardiovascular disease Diseases 0.000 description 8
- 230000003278 mimic effect Effects 0.000 description 7
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- 229920002971 Heparan sulfate Polymers 0.000 description 5
- 230000000712 assembly Effects 0.000 description 5
- 238000000429 assembly Methods 0.000 description 5
- 210000003855 cell nucleus Anatomy 0.000 description 5
- 210000003038 endothelium Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 230000001172 regenerating effect Effects 0.000 description 5
- 102000007330 LDL Lipoproteins Human genes 0.000 description 4
- 108010007622 LDL Lipoproteins Proteins 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 230000004962 physiological condition Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- 229920001503 Glucan Polymers 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 239000000560 biocompatible material Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 150000002540 isothiocyanates Chemical class 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 230000001019 normoglycemic effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000008052 Nitric Oxide Synthase Type III Human genes 0.000 description 2
- 108010075520 Nitric Oxide Synthase Type III Proteins 0.000 description 2
- 102000007637 Soluble Guanylyl Cyclase Human genes 0.000 description 2
- 108010007205 Soluble Guanylyl Cyclase Proteins 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000012606 in vitro cell culture Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002032 lab-on-a-chip Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008753 endothelial function Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000004963 pathophysiological condition Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004648 relaxation of smooth muscle Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003845 vascular endothelial function Effects 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/34—Internal compartments or partitions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/02—Membranes; Filters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/14—Scaffolds; Matrices
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0661—Smooth muscle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/48—Automatic or computerized control
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Immunology (AREA)
- Clinical Laboratory Science (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (18)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862778776P | 2018-12-12 | 2018-12-12 | |
US62/778,776 | 2018-12-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111394245A CN111394245A (zh) | 2020-07-10 |
CN111394245B true CN111394245B (zh) | 2024-05-14 |
Family
ID=68887316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911275786.7A Active CN111394245B (zh) | 2018-12-12 | 2019-12-12 | 用于筛选对内皮糖萼相关疾病具有预防和治疗活性的化合物的方法和装置 |
Country Status (3)
Country | Link |
---|---|
US (1) | US11319519B2 (zh) |
EP (1) | EP3666883A1 (zh) |
CN (1) | CN111394245B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3012985A1 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102124096A (zh) * | 2008-07-16 | 2011-07-13 | 儿童医疗中心有限公司 | 具有微通道的器官模仿装置及其使用和制造方法 |
WO2016191332A2 (en) * | 2015-05-22 | 2016-12-01 | President And Fellows Of Harvard College | Methods, systems, and compositions for determining blood clot formation, and uses thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7960166B2 (en) * | 2003-05-21 | 2011-06-14 | The General Hospital Corporation | Microfabricated compositions and processes for engineering tissues containing multiple cell types |
US20080017586A1 (en) * | 2006-02-15 | 2008-01-24 | Matousek Rudolf C | Ballast tank circulation management system |
US7725267B2 (en) | 2006-03-31 | 2010-05-25 | Cfd Research Corporation | Synthetic microfluidic microvasculature network |
CN101918845B (zh) * | 2007-11-30 | 2014-01-29 | 马斯特里赫特大学 | 评估糖萼状态的方法及其在鉴定血管相关疾病中的应用 |
US9595206B2 (en) | 2008-02-11 | 2017-03-14 | The General Hospital | System and method for in vitro blood vessel modeling |
CN101451105B (zh) | 2008-12-26 | 2011-06-08 | 中国科学院上海微系统与信息技术研究所 | 一种毛细血管模型的构建方法及其微系统芯片 |
US20100240086A1 (en) * | 2009-03-20 | 2010-09-23 | Dmitry Kashanin | Biochip assembly and assay method thereof |
EP2542663B1 (en) | 2010-08-06 | 2014-07-16 | TissUse GmbH | Circulation system |
US20130143230A1 (en) | 2011-12-02 | 2013-06-06 | The Trustees Of The Stevens Institute Of Technology | Microfluidic-based cell-culturing platform and method |
WO2013086486A1 (en) * | 2011-12-09 | 2013-06-13 | President And Fellows Of Harvard College | Integrated human organ-on-chip microphysiological systems |
WO2014127250A1 (en) | 2013-02-14 | 2014-08-21 | Cfd Research Corporation | Cell culture device with an array of microfluidic networks |
US10870823B2 (en) * | 2014-06-12 | 2020-12-22 | Lehigh University | Biomimetic device |
CA3007362A1 (en) | 2015-12-04 | 2017-06-08 | EMULATE, Inc. | Open-top microfluidic device with structural anchors |
SG11201900422TA (en) | 2016-07-18 | 2019-02-27 | Harvard College | Human lymphoid tissue-on-chip |
-
2019
- 2019-12-12 US US16/712,724 patent/US11319519B2/en active Active
- 2019-12-12 EP EP19215609.9A patent/EP3666883A1/en active Pending
- 2019-12-12 CN CN201911275786.7A patent/CN111394245B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102124096A (zh) * | 2008-07-16 | 2011-07-13 | 儿童医疗中心有限公司 | 具有微通道的器官模仿装置及其使用和制造方法 |
WO2016191332A2 (en) * | 2015-05-22 | 2016-12-01 | President And Fellows Of Harvard College | Methods, systems, and compositions for determining blood clot formation, and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
US20200199510A1 (en) | 2020-06-25 |
EP3666883A1 (en) | 2020-06-17 |
CN111394245A (zh) | 2020-07-10 |
US11319519B2 (en) | 2022-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2972313B1 (en) | Ported parallel plate flow chamber and methods for use thereof | |
US9969963B2 (en) | Methods and apparatus for cell culture array | |
US9637715B2 (en) | Cell culture and invasion assay method and system | |
Rothbauer et al. | Recent advances and future applications of microfluidic live-cell microarrays | |
US20150204763A1 (en) | System for analyzing biological sample material | |
US8802391B2 (en) | Method for measuring the migration of cells in a channel under the influence of an analyte | |
US20170234851A1 (en) | Methods and Apparatus for Segregation of Particles | |
CA2782176C (en) | Methods and apparatus for segregation of particles, including segregation and proliferation of fetal and stem cells | |
US20160272934A1 (en) | Systems, devices and methods for microfluidic culturing, manipulation and analysis of tissues and cells | |
US20180298343A1 (en) | Compositions and methods for a three dimensional ex-vivo glomerular cell co-culture biological engineering model | |
AU2005222931A1 (en) | Methods and apparatus for integrated cell handling and measurements | |
WO2015061458A1 (en) | Systems, devices and methods for microfluidic culturing, manipulation and analysis of tissues and cells | |
EP3298161B1 (en) | Methods, systems, and compositions for determining blood clot formation, and uses thereof | |
EP3596465A1 (en) | Biochip having microchannel provided with capturing agent for performing cytological analysis | |
CN111394245B (zh) | 用于筛选对内皮糖萼相关疾病具有预防和治疗活性的化合物的方法和装置 | |
EP1941030A1 (en) | Cell migration assay | |
EP4240825A1 (en) | Devices and methods for monitoring cells, tissues, or organs-on-a-chip | |
WO2016054288A1 (en) | A human liver microphysiology platform and self assembly liver acinus model and methods of their use | |
Kucukal | Biomimetic Microfluidic Platforms for Monitoring Cellular Interactions in Microscale Flow | |
Verpoorte et al. | How microtechnologies enable organs-on-a-chip | |
Maria-Roxana et al. | DETECTION OF MODIFIED CELLS USING" LAB-ON-A-CHIP (LOC)" MICROFLUIDIC DEVICES. | |
Glieberman | In Vitro Models for the Pancreatic Islet Using Dynamic Secretion Sensing and Mechanical Stimulation | |
Carciati et al. | Red blood cells under flow: blood rheology and effect of vascular endothelial cells on haemodynamics in vitro | |
AU2014340146A1 (en) | Systems, devices and methods for microfluidic culturing, manipulation and analysis of tissues and cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240521 Address after: 519031 Office 835, No. 258 Haojiang Road, Hengqin, Zhuhai City, Guangdong Province Patentee after: Zhongke Hesheng Biotechnology (Zhuhai Hengqin) Co.,Ltd. Country or region after: China Patentee after: Kangleyi Health Science Co.,Ltd. Country or region after: U.S.A. Address before: No.6, Anmin Road, Huangdai Town, Xiangcheng District, Suzhou City, Jiangsu Province Patentee before: ZHONGKE XINRAY (SUZHOU) BIOLOGICAL TECHNOLOGY Co.,Ltd. Country or region before: China Patentee before: Kangleyi Health Science Co.,Ltd. Country or region before: U.S.A. |